chr3-143266788-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_173653.4(SLC9A9):āc.1852A>Gā(p.Lys618Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000489 in 1,614,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Synonymous variant affecting the same amino acid position (i.e. K618K) has been classified as Likely benign.
Frequency
Consequence
NM_173653.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC9A9 | NM_173653.4 | c.1852A>G | p.Lys618Glu | missense_variant | 16/16 | ENST00000316549.11 | NP_775924.1 | |
SLC9A9 | XM_017006203.2 | c.1501A>G | p.Lys501Glu | missense_variant | 15/15 | XP_016861692.1 | ||
SLC9A9 | XM_011512703.4 | c.1204A>G | p.Lys402Glu | missense_variant | 13/13 | XP_011511005.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC9A9 | ENST00000316549.11 | c.1852A>G | p.Lys618Glu | missense_variant | 16/16 | 1 | NM_173653.4 | ENSP00000320246 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152220Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251446Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135886
GnomAD4 exome AF: 0.0000479 AC: 70AN: 1461888Hom.: 0 Cov.: 31 AF XY: 0.0000509 AC XY: 37AN XY: 727248
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.1852A>G (p.K618E) alteration is located in exon 16 (coding exon 16) of the SLC9A9 gene. This alteration results from a A to G substitution at nucleotide position 1852, causing the lysine (K) at amino acid position 618 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at